Global Altitude Sickness (Acute Mountain Sickness) Clinical Trials Review, H2, 2018 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Altitude Sickness (Acute Mountain Sickness) Global Clinical Trials Review, H2, 2018" clinical trials has been added to ResearchAndMarkets.com's offering.

This report provides top line data relating to the clinical trials on Altitude Sickness (Acute Mountain Sickness). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

The report also provides prominent drugs for in-progress trials (based on number of ongoing trials). These reports are generated using a proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Key Topics Covered:

1. List of Tables
2. List of Figures
3. Report Guidance
4. Clinical Trials Report Coverage
5. Clinical Trials by Region
6. Clinical Trials and Average Enrollment by Country
7. Top Five Countries Contributing to Clinical Trials in Asia-Pacific
8. Top Countries Contributing to Clinical Trials in Europe
9. Top Countries Contributing to Clinical Trials in North America
10. Top Countries Contributing to Clinical Trials in Middle East and Africa
11. Top Countries Contributing to Clinical Trials in Central and South America
12. Clinical Trials by G7 Countries: Proportion of Altitude Sickness (Acute Mountain Sickness) to Respiratory Clinical Trials
13. Clinical Trials by Phase in G7 Countries
14. Clinical Trials in G7 Countries by Trial Status
15. Clinical Trials by E7 Countries: Proportion of Altitude Sickness (Acute Mountain Sickness) to Respiratory Clinical Trials
16. Clinical Trials by Phase in E7 Countries
17. Clinical Trials by Phase
18. In Progress Trials by Phase
19. Clinical Trials by Trial Status
20. Clinical Trials by End Point Status
21. Subjects Recruited Over a Period of Time
22. Clinical Trials by Sponsor Type
23. Prominent Sponsors
24. Top Companies Participating in Altitude Sickness (Acute Mountain Sickness) Therapeutics Clinical Trials
25. Prominent Drugs
26. Clinical Trial Profile Snapshots
27. Appendix

Companies Mentioned

• Tasly Holding Group Company Ltd
• Wellcome Trust
• Director General Armed Forces Medical Services
• QinetiQ Ltd
• Johnson & Johnson
• Istituto Auxologico Italiano
• CJ CheilJedang Corp
• Apex
• Altitude Organic Medicine
• A. Menarini Industrie Farmaceutiche Riunite Srl

For more information about this clinical trials report visit https://www.researchandmarkets.com/research/xzfm83/global_altitude?w=4